Bionsight Enters R&D Collaboration Agreement with Astellas for First-in-Class Autoimmune Disorder Therapy
Bionsight, an AI-powered chemoproteomics drug discovery company, today announced that it has entered into a global R&D collaboration agreement with Astellas Pharma Inc.
